维普中文期刊产品整合服务
60篇 您的检索式:作者名="Lachenmayer"
    题名 作者 年代 出处 被引量
1Inflammatory myofibroblastic tumor of the liver:A case report and review of literature显示文摘BACKGROUND Inflammatory myofibroblastic tumors of the liver(IMTL)are extremely rare neoplasms and very little is known about their clinical presentation,pathogenesis,and biological behavior.Due to their absolute rarity,it is almost impossible to obtain a definite diagnosis without histological examination.Because of their intermediate biological behavior with the risk for local recurrence and metastases,surgical resection is recommend whenever IMTL is suspect.CASE SUMMARY We herein present a case of an otherwise healthy 32-year-old woman who presented with intermittent fever,unclear anemia,malaise and right flank pain 4 mo postpartum.The liver mass in segment IVa/b was highly FDG avid in the positron emission tomography-computed tomography.Hepatic resection was performed achieving a negative resection margin and an immediate resolution of all clinical symptoms.Histological analysis diagnosed the rare finding of an inflammatory myofibroblastic tumor of the liver and revealed cytoplasmic anaplastic lymphoma kinase expression by immunohistochemistry.Twelve months follow-up magnetic resonance imaging showed no recurrence and no metastases in the fully recovered patient.CONCLUSION IMTLs are extremely rare and difficult to diagnose.Due to their intermediate biological behavior,surgical resection should be perform whenever feasible and patients should be followed-up in order to detect recurrence and metastasis as early as possible.Alexandra Filips Martin H Maurer Matteo Montani Guido Beldi Anja Lachenmayer 2020World Journal of Hepatology2020,12,4:4
2Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent Advancements显示文摘Yujin Hoshida Sara Toffanin Anja Lachenmayer Augusto Villanueva Beatriz Minguez Josep Llovet 2010Semin Liver Dis2010,,01:2
3Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib显示文摘Anja Lachenmayer Clara Alsinet Radoslav Savic Laia Cabellos Sara Toffanin Yujin Hoshida Augusto Villanueva Beatriz Minguez Philippa Newell Hung-Wen Tsai Jordi Barretina Swan Thung Stephen C. Ward Jordi Bruix Vincenzo Mazzaferro Myron Schwartz Scott L. Fri 2012Clinical Cancer Research2012,,18:2
4Prolonged vasospaam in migrainedetected by noninvasive transcraniai doppler ultrasound显示文摘Thie A Spitzer K Lachenmayer L 1988Headache1988,28,:1
5Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model显示文摘STEELE J W LACHENMAYER M L JU S 2013Molecular Psychiatry2013,18,8:1
6Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib显示文摘Anja Lachenmayer Sara Toffanin Laia Cabellos Clara Alsinet Yujin Hoshida Augusto Villanueva Beatriz Minguez Hung-Wen Tsai Stephen C. Ward Swan Thung Scott L. Friedman Josep M. Llovet 2012Journal of Hepatology2012,,6:1
7Latrepirdine improvescognition and arrests progression of neuropathology in anAlzheimer, s mouse model 显示文摘Steele JW Lachenmayer ML Ju S 2012Mol Psychiatry2012,18,8:1
8Combination therapy for hepatocellular carcinoma:Additive preclmical efficacy of the HDAC inhibitor panobinostat with sorafenib显示文摘Lachenmayer A Toffanin S Cabellos L 0,,06:1
9Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib显示文摘Anja Lachenmayer Clara Alsinet Radoslav Savic Laia Cabellos Sara Toffanin Yujin Hoshida Augusto Villanueva Beatriz Minguez Philippa Newell Hung-Wen Tsai Jordi Barretina Swan Thung Stephen C. Ward Jordi Bruix Vincenzo Mazzaferro Myron Schwartz Scott L. Fri 2012Clinical Cancer Research2012,,18:1
10Diagnostic and prognostic molecular markers in hepatocellular carcinoma 显示文摘M~nguez B Lachenmayer A 2011Dis Markers2011,31,3:1
11Prolonged vasospasm in migraine detected by noninvasive transcranial Doppler ultrasound显示文摘 Spitzer K Lachenmayer L 1988Headache1988,28,:1
12Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib显示文摘Lachenmayer A Alsinet C Savic R 2012Clin Cancer Res2012,18,18:1
13Wnt - pathway activation in two molecular classes of hepatocellular carcinoma and experi- mental modulation by sorafenib 显示文摘J Lachenmayer A Alsinet C Savic R 2012Clin Cancer Res2012,18,18:1
14Wnt-pathway activation intwo molecular classes of hepatocellular carcinoma and experimentalmodulation by sorafenib 显示文摘Lachenmayer A Alsinet C Savic R 2012Clin Cancer Res2012,18,18:1
15Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance ofprotein aggregates 显示文摘Lim J Lachenmayer M L Wu S 2015PloS Genet2015,11,2:1
16Thymolipoma in association with myasthenia gravis显示文摘Otto HF Loning T Lachenmayer L 1982Cancer1982,50,8:1
17Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib显示文摘Lachenmayer A Toffanin S Cabellos L 2012J Hepatol2012,56,6:1
18Dissection of the extracranial vertebral artery:report of four cases and review of the literature显示文摘Hinse P Thie A Lachenmayer L 1991J Neurol Neurosurg Psychiatry1991,54,:1
19Prolonged vasospasm in mi- graine detected by noninvasive transcranial doppler ultrasound 显示文摘Thie A Spitzer K Lachenmayer L 1988Headache1988,28,3:1
20MicroR- NA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a 显示文摘Toffhnin S Hoshida Y Lachenmayer A 2011Gastroenterology2011,140,5:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费